These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study. OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265 [TBL] [Abstract][Full Text] [Related]
3. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses. Kasiske BL; Kukla A; Thomas D; Wood Ives J; Snyder JJ; Qiu Y; Peng Y; Dharnidharka VR; Israni AK Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332 [TBL] [Abstract][Full Text] [Related]
4. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience. Wasson S; Zafar MN; Best J; Reddy HK J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222 [TBL] [Abstract][Full Text] [Related]
5. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. Caillard S; Porcher R; Provot F; Dantal J; Choquet S; Durrbach A; Morelon E; Moal V; Janbon B; Alamartine E; Pouteil Noble C; Morel D; Kamar N; Buchler M; Mamzer MF; Peraldi MN; Hiesse C; Renoult E; Toupance O; Rerolle JP; Delmas S; Lang P; Lebranchu Y; Heng AE; Rebibou JM; Mousson C; Glotz D; Rivalan J; Thierry A; Etienne I; Moal MC; Albano L; Subra JF; Ouali N; Westeel PF; Delahousse M; Genin R; Hurault de Ligny B; Moulin B J Clin Oncol; 2013 Apr; 31(10):1302-9. PubMed ID: 23423742 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder. Rouphael B; Lankireddy S; Lazaryan A; Kukla A; Ibrahim HN; Matas AJ; Issa N Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation. Birkeland SA; Hamilton-Dutoit S; Bendtzen K Transplantation; 2003 Jul; 76(1):153-8. PubMed ID: 12865802 [TBL] [Abstract][Full Text] [Related]
8. Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study. Francis A; Johnson DW; Teixeira-Pinto A; Craig JC; Wong G Nephrol Dial Transplant; 2018 May; 33(5):881-889. PubMed ID: 29342279 [TBL] [Abstract][Full Text] [Related]
9. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients. Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients. Morton M; Coupes B; Roberts SA; Klapper PE; Byers RJ; Vallely PJ; Ryan K; Picton ML Transplantation; 2013 Feb; 95(3):470-8. PubMed ID: 23222821 [TBL] [Abstract][Full Text] [Related]
11. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland. Steiner R; Kridel R; Giostra E; McKee T; Achermann R; Mueller N; Manuel O; Dickenmann M; Schuurmans MM; de Leval L; Fehr T; Tinguely M; Binet I; Cogliatti S; Haralamvieva E; Koller M; The Swiss Transplant Cohort Study Stcs ; Dietrich PY Swiss Med Wkly; 2018; 148():w14596. PubMed ID: 29518251 [TBL] [Abstract][Full Text] [Related]
12. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S; Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985 [TBL] [Abstract][Full Text] [Related]
13. Posttransplant lymphoproliferative disorder after liver and kidney transplant. Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813 [TBL] [Abstract][Full Text] [Related]
14. Post-transplantation lymphoproliferative disorder in pediatric kidney-transplant recipients - a national study. Cleper R; Ben Shalom E; Landau D; Weissman I; Krause I; Konen O; Rahamimov R; Mor E; Bar-Nathan N; Frishberg Y; Davidovits M Pediatr Transplant; 2012 Sep; 16(6):619-26. PubMed ID: 22708682 [TBL] [Abstract][Full Text] [Related]